Vor Biopharma Inc. (VOR)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
18. 09
+0.75
+4.3253%
$
126.8M Market Cap
- P/E Ratio
- Div Yield
999,000 Volume
-1.43 Eps
$ 17.34
Previous Close Want to track VOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vor Biopharma Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| ML Marc Larkins Johnson & Johnson | 53,732 | $2.62M | $986,519.52 | -$1.63M | -62.32% |
 David Kim Paradigm Biocapital Advisors LP | 1.75M | $22.89M | $31.97M | $9.08M | 39.68% |
| SRB Steve R. Bailey Frazier Life Sciences Management LP | 2.54M | $33.27M | $46.77M | $13.5M | 40.56% |
| KMT Kirk M. Tokheim Ameritas Advisory Services LLC | 37 | $660.08 | $677.7 | $17.62 | 2.67% |
 Li Peng China Universal Asset Management Co. Ltd. | 7,368 | $118,374.16 | $134,760.72 | $16,386.56 | 13.84% |
| TK Taro Kuriyama Axq Capita LLP | 15,019 | $267,939 | $272,519.75 | $4,580.75 | 1.71% |
| KJ Ken Joseph Braidwel LLP | 466,774 | $8.33M | $8.37M | $46,677.54 | 0.56% |
 Josh Brodman Irenic Capital Management LP | 32,663 | $582,708 | $591,690.24 | $8,982.24 | 1.54% |
| DP Drew Phillips Fortitude Family Office LLC | 31 | $553 | $557.07 | $4.07 | 0.74% |
 Jim Harding Propel Bio Management LLC | 314,543 | $5.59M | $5.5M | -$86,010.93 | -1.54% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 372 | $5,065.23 | $6,630.9 | $1,565.67 | 30.91% |
 Nicole Reese WPG Advisers LLC | 21 | $375 | $375.27 | $0.27 | 0.07% |
